Insiders · Profile

Meyers James R

EVP Worldwide Commercial Ops at Gilead Sciences. Filing since 28 Feb 2007. CIK 0001387521

Company
Date
Role
Action
Shares
Amount
Of holding
16 Jan 2018
EVP Worldwide Commercial Ops
Sold, plan not stated
100,000
$8.02M
97.4%
31 Aug 2017
EVP Worldwide Commercial Ops
Sold, plan not stated
60,000
$4.99M
95.7%
24 Apr 2007
SVP Comm Ops North America
Sold, plan not stated
9,000
$748.58K
89.7%
28 Feb 2007
SVP Comm Ops North America
Sold, plan not stated
6,000
$428.09K
85.4%
4 decisions on file.